Need a specific person's email?
Browse Exosome Diagnostics, a subsidiary of mdxhealth's employee directory (about 59 employees) and reveal verified emails free.
Exosome Diagnostics, a subsidiary of mdxhealth's most common email format is FLast@exosomedx.com (ex. JDoe@exosomedx.com), used for 85% of exosomedx.com addresses. Exosome Diagnostics, a subsidiary of mdxhealth uses 8 email patterns across 2 domains: exosomedx.com and bio-techne.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of exosomedx.com |
|---|---|---|
| FLast@exosomedx.comMost common | JDoe@exosomedx.com | |
| First@exosomedx.com | John@exosomedx.com | |
| FiLast@exosomedx.com | JoDoe@exosomedx.com | |
| FirstL@exosomedx.com | JohnD@exosomedx.com |
| Format | Example | Share of bio-techne.com |
|---|---|---|
| First.Last@bio-techne.comMost common | John.Doe@bio-techne.com | |
| FirstLast@bio-techne.com | JohnDoe@bio-techne.com | |
| First@bio-techne.com | John@bio-techne.com | |
| Last.First@bio-techne.com | Doe.John@bio-techne.com |
Browse Exosome Diagnostics, a subsidiary of mdxhealth's employee directory (about 59 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States51-200 Employees
Exosome Diagnostics, Inc., a subsidiary of mdxhealth, operates in the biotechnology research sector with a focus on minimally invasive molecular diagnostics derived from blood and urine. By analyzing exosomes, which carry nucleic acid profiles from cancers and other diseases, the company aims to enable doctors to select more effective therapies for cancer and related conditions. Its products and research address the needs of clinicians seeking liquid biopsy approaches that can provide actionable molecular information from readily accessible body fluids. Based in Waltham, Massachusetts, the company positions itself within the field of liquid biopsy and cancer diagnostics, offering services and assays that have been highlighted through various industry updates since its involvement in the development and commercialization of Exosome-based tests. A key recent development noted is the publication of a paper on exosome-based liquid biopsies in a peer-reviewed journal, signaling ongoing academic collaboration and visibility in the field. The organization is part of Bio-Techne, through its branding of Exosome Diagnostics.
Most common format
FLast@exosomedx.com
Example: JDoe@exosomedx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.